Clinical and response characteristics of all patients enrolled in the phase 2 study. (A) Swimmer plot of dynamic response assessment. (B) OS of all patients. (C) DOR for patients who had CCr (CR + CRi + MLFS). (D) EFS of all patients. (E) Simon-Makuch plots of the impact of HSCT on OS. (F) Simon-Makuch plots of the impact of HSCT on EFS. NR, not reached.